한글목차

세계의 AMH FIA 검사 시장의 미래는 의료와 과학 연구 시장에서의 기회로 유망시되고 있습니다. 세계의 AMH FIA 검사 시장은 2025-2031년에 CAGR 11.5%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 불임 및 생식 보건에 대한 인식 증가, 진단 기술의 발전, 의료 투자 증가 등입니다.

• Lucintel의 예측에 따르면 유형별로는 생물학적 시료의 보존 및 보존 기간 연장으로 인해 저온보존이 예측 기간 중 높은 성장을 보일 것으로 예측됩니다.
• 용도별로는 불임 검사, 생식 건강, 여성 건강에 대한 관심이 높아지면서 의료 분야가 높은 성장세를 보일 것으로 예측됩니다.
• 지역별로는 북미가 예측 기간 중 가장 높은 성장세를 보일 것으로 예측됩니다.

AMH FIA 검사 시장의 새로운 동향

AMH FIA 검사 시장은 생식 의료 기술의 발전, 불임에 대한 사회적 태도의 변화, 진단 툴의 개선으로 인해 몇 가지 중요한 추세에 있습니다. 이러한 추세는 불임 검사 및 치료 옵션을 재구성하고 난소 예비력 평가에 대한 광범위한 접근성과 정확성을 향상시키고 있습니다. 이러한 동향을 이해하는 것은 시장 기회를 활용하고자 하는 이해관계자들에게 필수적입니다.

• 가임력 보존에 대한 수요 증가: 특히 출산을 미루는 여성들 사이에서 가임력 보존에 대한 관심이 높아지고 있는 것은 AMH FIA 검사 시장의 주요 촉진요인 중 하나입니다. 난자 동결이나 불임 치료를 늦게까지 선택하는 여성들이 늘어나면서 AMH 검사에 대한 수요가 증가하고 있습니다. AMH 검사는 난소예비력 판단 및 가임력 보존에 대한 의사결정의 지침이 되므로 클리닉이나 병원에서 귀중한 툴로 활용되고 있습니다.
• 검사 기술의 발전: 진단 기술의 발전으로 AMH FIA 검사의 정확도와 속도가 향상되고 있습니다. 자동화, 검사 장비의 소형화, 고감도 검사 등의 기술 혁신으로 AMH 검사는 더욱 편리하고 신뢰할 수 있는 검사로 발전하고 있습니다. 이러한 기술적 진보는 보다 빠른 결과를 가능하게 하고, 환자의 대기 시간을 단축시키며, 전 세계 임상 현장에서 AMH 검사의 채택을 촉진하고 있습니다.
• 신흥 시장에서의 활용성 확대: AMH FIA 검사 시장은 인도, 중국, 브라질과 같은 신흥 시장에서 채택이 확대되고 있습니다. 불임 문제에 대한 인식이 높아지고, 첨단 진단 기술이 보급되면서 이들 지역에서는 AMH 검사에 대한 수요가 증가하고 있습니다. 의료 인프라가 개선되고 더 많은 불임 클리닉이 개설됨에 따라 AMH 검사 시장은 선진국 외의 지역으로 확대될 것입니다.
• 보조생식술(ART)과의 통합: AMH 검사는 IVF, 시험관아기 시술과 같은 ART 시술에 통합되고 있습니다. 불임 클리닉에서 AMH 검사를 통해 난소 예비력을 평가하면 의사는 더 나은 결과를 얻기 위해 치료 계획을 조정할 수 있습니다. 개별화된 불임 치료에 대한 관심 증가와 함께 ART 시술 증가는 ART 진단 과정의 일부로 AMH 검사의 채택을 촉진하고 있습니다.
• 여성 건강과 생식권에 대한 관심 증가: 여성 건강, 특히 생식권에 대한 인식과 관심이 높아지면서 AMH 검사의 보급에 기여하고 있습니다. 여성들이 자신의 생식능력에 대해 충분한 정보를 바탕으로 결정권을 갖게 되면서 AMH 검사에 대한 수요가 증가하고 있습니다. 이러한 추세는 AMH 검사가 생식 잠재력을 이해하는 데 있으며, 중심적인 역할을 하는 보다 적극적인 헬스케어로의 전환을 반영합니다.

이러한 추세는 AMH FIA 검사 시장이 가임력 보존에 대한 수요 증가, 기술 발전, 신흥 시장에서의 채택 확대로 인해 빠르게 진화하고 있음을 보여줍니다. ART 시술에 AMH 검사가 통합되고 여성 생식 건강에 대한 관심이 높아지면서 시장이 재편되고 있으며, 혁신과 성장의 새로운 기회를 창출하고 있습니다.

AMH FIA 검사 시장의 최근 동향

AMH FIA 검사 시장은 기술 발전, 가임력 보존에 대한 수요 증가, 검사에 대한 접근성 확대로 인해 빠르게 발전하고 있습니다. 이러한 발전은 전 세계 의료 시스템의 변화와 여성의 생식 건강에 대한 강조를 반영하고 있습니다. 다음은 AMH FIA 검사 시장 전망를 형성하는 5 가지 주요 개발입니다.

• 검사 감도와 정확도의 발전: 최근 검사 감도와 정확도의 발전으로 AMH FIA 검사의 신뢰성이 향상되고 있습니다. 제조업체들은 보다 정밀한 검사 키트를 도입하여 보다 신속하고 정확한 결과를 제공함으로써 위양성 및 위음성의 가능성을 줄이고 있습니다. 이 개발은 난소 예비력의 정확한 측정이 정보에 입각한 의사결정에 필수적인 불임 치료에서 매우 중요한 의미를 갖습니다.
• 불임 클리닉에서의 사용 증가: 전 세계 불임 클리닉에서 AMH FIA 검사가 난소 예비력을 평가하기 위한 표준 절차로 채택되고 있습니다. 이러한 추세는 특히 미국과 유럽에서 두드러지며, 불임 클리닉에서는 일상적인 불임 평가의 일환으로 이 검사를 시행하고 있습니다. 이러한 클리닉에서 AMH 검사를 이용할 수 있게 됨에 따라 더 많은 여성들이 자신의 임신 가능성을 이해하고 가족계획에 대한 적극적인 결정을 내릴 수 있게 되었습니다.
• 생식 건강진단에 AMH 검사 통합: AMH 검사는 특히 출산 지연을 고려하는 여성을 위해 일상적인 생식 건강 검진에 포함되고 있습니다. AMH 검사를 다른 생식 기능 관련 평가와 통합하여 여성의 생식 건강 상태를 종합적으로 파악할 수 있으며, 의료 서비스 프로바이더는 불임 보존 및 치료와 관련하여 보다 맞춤화된 맞춤형 조언을 제공할 수 있습니다.
• 불임에 대한 인식이 높아짐에 따라 중국, 인도, 브라질과 같은 국가에서는 AMH 검사에 대한 수요가 증가하고 있습니다. 현지 의료 서비스 프로바이더들은 불임 관련 진단에 대한 수요 증가에 대응하기 위해 AMH FIA 검사를 채택하고 있습니다. AMH 검사가 저렴한 가격과 의료 인프라의 개선과 함께 이들 신흥 시장에서 AMH 검사의 채택이 가속화되고 있습니다.
• 불임 치료에 대한 정부 지원: 많은 국가에서 정부는 보조금이나 보험 적용을 통해 불임 치료를 지원하고 있습니다. 그 일환으로 AMH 검사는 더 많은 사람들이 쉽게 이용할 수 있게 되었습니다. 특히 고령 여성의 불임 문제를 해결하기 위한 정부 정책이 보조생식술(ART) 치료의 일환으로 AMH 검사에 대한 수요를 촉진하고 있습니다.

이러한 발전은 기술 발전, 불임 치료 수요 증가, 선진국과 신흥 시장 모두에서 접근성 확대로 인해 AMH FIA 검사 시장이 지속적으로 성장하고 있음을 보여줍니다. 이러한 추세가 지속된다면, AMH 검사 시장은 더욱 확대될 것이며, 혁신과 생식 헬스케어 개선의 새로운 기회를 제공할 것입니다.

목차

제1장 개요

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 거시경제 동향과 예측
• 산업 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 AMH FIA 검사 시장(유형별)

• 개요
• 유형별 매력 분석
• 저온 보존 : 동향과 예측(2019-2031년)
• 실온 보관 : 동향과 예측(2019-2031년)

제5장 세계의 AMH FIA 검사 시장(용도별)

• 개요
• 용도별 매력 분석
• 의료 : 동향과 예측(2019-2031년)
• 과학 연구 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 지역별 AMH FIA 검사 시장

제7장 북미의 AMH FIA 검사 시장

• 개요
• 미국의 AMH FIA 검사 시장
• 멕시코의 AMH FIA 검사 시장
• 캐나다의 AMH FIA 검사 시장

제8장 유럽의 AMH FIA 검사 시장

• 개요
• 독일의 AMH FIA 검사 시장
• 프랑스의 AMH FIA 검사 시장
• 스페인 AMH FIA 검사 시장
• 이탈리아의 AMH FIA 검사 시장
• 영국의 AMH FIA 검사 시장

제9장 아시아태평양의 AMH FIA 검사 시장

• 개요
• 일본의 AMH FIA 검사 시장
• 인도의 AMH FIA 검사 시장
• 중국의 AMH FIA 검사 시장
• 한국의 AMH FIA 검사 시장
• 인도네시아의 AMH FIA 검사 시장

제10장 기타 지역의 AMH FIA 검사 시장

• 개요
• 중동의 AMH FIA 검사 시장
• 남미의 AMH FIA 검사 시장
• 아프리카의 AMH FIA 검사 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간 경쟁 관계
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 대체품의 위협
  • 신규 진출업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 유형별 성장 기회
  • 용도별 성장 기회
• 세계의 AMH FIA 검사 시장에서의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증과 라이선싱
  • 합병, 인수, 계약, 제휴, 합병사업

제13장 밸류체인 전체에 걸친 주요 기업의 기업 개요

• 경쟁 분석
• CTK BIoTech
• Medline
• Guangzhou Wanfu Biology Technology
• BIoTime
• Wondfo
• Biolab Diagnostics
• Boditech Med

제14장 부록

• 도표
• 표 리스트
• 조사 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• Lucintel 소개
• 문의처

영문목차

The future of the global AMH FIA test market looks promising with opportunities in the medical and scientific research markets. The global AMH FIA test market is expected to grow with a CAGR of 11.5% from 2025 to 2031. The major drivers for this market are the increasing awareness of fertility & reproductive health, the advancements in diagnostic technology, and the increased healthcare investments.

• Lucintel forecasts that, within the type category, cryogenic storage is expected to witness higher growth over the forecast period due to preservation of biological samples & longer shelf life.
• Within the application category, medical is expected to witness the higher growth due to fertility testing and reproductive health, increasing focus on women's health.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the AMH FIA Test Market

The AMH FIA test market is undergoing several key trends, driven by advancements in reproductive health technologies, shifts in societal attitudes toward fertility, and improvements in diagnostic tools. These trends are reshaping the landscape of fertility testing and treatment options, leading to broader access and enhanced precision in assessing ovarian reserve. Understanding these trends is essential for stakeholders looking to capitalize on market opportunities.

• Rising Demand for Fertility Preservation: The growing trend of fertility preservation, particularly among women delaying childbirth, is one of the key drivers in the AMH FIA test market. As more women choose to freeze their eggs or pursue fertility treatments later in life, the demand for AMH testing increases. AMH tests help determine ovarian reserve and guide decisions regarding fertility preservation, making it a valuable tool in clinics and hospitals.
• Technological Advancements in Testing: Advancements in diagnostic technology are improving the accuracy and speed of AMH FIA tests. Innovations such as automation, miniaturization of testing devices, and higher sensitivity tests have made AMH testing more accessible and reliable. These technological advancements enable faster results, reducing wait times for patients, and driving the adoption of AMH tests in clinical settings globally.
• Expanding Availability in Emerging Markets: The AMH FIA test market is seeing increased adoption in emerging markets like India, China, and Brazil. With rising awareness of fertility issues and the growing availability of advanced diagnostic technologies, demand for AMH tests is increasing in these regions. As healthcare infrastructure improves and more fertility clinics open, the market for AMH testing expands beyond developed countries.
• Integration with Assisted Reproductive Technologies (ART): AMH testing is increasingly integrated into ART procedures such as IVF and IUI. As fertility clinics use AMH tests to assess ovarian reserve, doctors can tailor treatment plans for better outcomes. The rise in ART procedures, combined with the increased focus on personalized fertility care, is driving the adoption of AMH tests as part of the ART diagnostic process.
• Increased Focus on Women's Health and Reproductive Rights: The rising awareness and focus on women's health, particularly around reproductive rights, are contributing to the growing use of AMH tests. As women become more empowered to make informed decisions about their fertility, there is greater demand for AMH testing. This trend reflects a broader shift toward proactive healthcare, with AMH tests playing a central role in understanding reproductive potential.

These trends indicate that the AMH FIA test market is evolving rapidly, with increased demand for fertility preservation, technological advancements, and wider adoption across emerging markets. The integration of AMH testing in ART procedures and the growing focus on women's reproductive health are reshaping the market and creating new opportunities for innovation and growth.

Recent Developments in the AMH FIA Test Market

The AMH FIA test market has been evolving rapidly, with significant advancements in technology, increased demand for fertility preservation, and expanding access to testing. These developments reflect shifts in healthcare systems globally and a greater emphasis on women's reproductive health. Below are five key developments that are shaping the future of the AMH FIA test market.

• Advancement of Test Sensitivity and Accuracy: Recent advancements in test sensitivity and accuracy have enhanced the AMH FIA test's reliability. Manufacturers have introduced more precise testing kits, which offer quicker and more accurate results, reducing the chances of false positives and negatives. This development is crucial in fertility care, where precise measurement of ovarian reserve is essential for making informed decisions.
• Increasing Availability in Fertility Clinics: Fertility clinics worldwide are increasingly adopting AMH FIA testing as a standard procedure for assessing ovarian reserve. This trend is particularly evident in the U.S. and Europe, where fertility clinics offer the test as part of routine fertility evaluations. The growing availability of AMH testing in these clinics is helping more women understand their fertility potential and make proactive decisions about family planning.
• Integration of AMH Testing in Reproductive Health Screenings: AMH testing is increasingly being included in routine reproductive health screenings, particularly for women considering delayed childbirth. The integration of AMH testing with other fertility-related assessments provides a comprehensive picture of a woman's reproductive health, enabling healthcare providers to offer more personalized and targeted advice on fertility preservation or treatment.
• Adoption in Emerging Markets: As fertility awareness increases, countries like China, India, and Brazil are seeing rising demand for AMH testing. Local healthcare providers are adopting AMH FIA tests to meet the growing demand for fertility-related diagnostics. The affordability of AMH tests, combined with improvements in healthcare infrastructure, is accelerating adoption in these emerging markets.
• Government Support for Fertility Treatments: In many countries, governments are increasingly supporting fertility treatments through subsidies and insurance coverage. As part of this, AMH testing is becoming more accessible to a larger population. Government policies aimed at addressing infertility issues, especially among older women, are driving the demand for AMH testing as part of assisted reproductive technology (ART) treatments.

These developments highlight the ongoing growth of the AMH FIA test market, driven by advancements in technology, increased demand in fertility care, and broader access in both developed and emerging markets. As these trends continue, the market for AMH testing will likely expand further, offering new opportunities for innovation and improved reproductive healthcare.

Strategic Growth Opportunities in the AMH FIA Test Market

The AMH FIA test market presents several strategic growth opportunities across various applications, particularly in fertility assessment, healthcare diagnostics, and assisted reproductive technologies. These opportunities reflect the expanding demand for reproductive health services and the increasing awareness of fertility preservation. Below are key growth opportunities in the AMH FIA test market, each offering potential for further market expansion.

• Fertility Clinics and IVF Centers: Fertility clinics and IVF centers represent a significant growth opportunity for the AMH FIA test market. As more individuals and couples seek fertility treatments, the demand for AMH testing increases. Fertility clinics can use AMH tests to assess ovarian reserve and guide treatment plans, making it an essential tool in fertility care.
• Women's Health and Reproductive Rights Advocacy: The growing emphasis on women's reproductive rights and health provides opportunities for AMH testing in preventive healthcare. As women become more proactive in managing their reproductive health, there is a growing market for AMH tests in routine screenings and fertility assessments, driving adoption across a broader demographic.
• Expansion into Emerging Markets: Emerging markets like India, China, and Brazil present significant growth opportunities for AMH testing. With increasing awareness of fertility issues and improvements in healthcare infrastructure, these regions are adopting AMH testing at a faster rate. Targeting these markets with affordable and accessible testing solutions can significantly expand the market footprint.
• Integration with Health and Wellness Platforms: AMH testing is becoming more integrated into digital health and wellness platforms, where women can track their reproductive health and fertility status. Partnerships between AMH test manufacturers and telemedicine platforms or fertility apps present a unique growth opportunity, enabling remote consultations and access to testing results.
• Adoption in Routine Healthcare Screenings: The inclusion of AMH testing in routine healthcare screenings for women, especially those delaying childbirth, presents a growing opportunity. Healthcare providers can offer AMH testing as part of standard wellness check-ups, allowing women to assess their ovarian reserve early and make informed decisions about fertility preservation.

These growth opportunities reflect the expanding demand for AMH testing across fertility, women's health, and emerging markets. By capitalizing on these opportunities, companies in the AMH FIA test market can drive expansion and further innovate in reproductive healthcare solutions.

AMH FIA Test Market Driver and Challenges

The AMH FIA test market is shaped by various drivers and challenges that influence its growth and adoption. Technological advancements, rising awareness about fertility issues, and regulatory factors all play a significant role in shaping the market's trajectory. However, challenges such as cost, access to testing, and regulatory hurdles also impact market growth. Below are the key drivers and challenges in the AMH FIA test market.

The factors responsible for driving the AMH FIA test market include:

1. Growing Fertility Awareness: The increasing awareness of fertility issues is a major driver for the AMH FIA test market. More individuals and couples are seeking fertility treatments, which drives demand for diagnostic tests like AMH to assess ovarian reserve and guide fertility care.

2. Technological Advancements in Diagnostics: Technological innovations, such as automated testing systems and improved test sensitivity, are driving the growth of the AMH FIA test market. These advancements make AMH testing faster, more accurate, and more accessible, leading to wider adoption in fertility clinics and healthcare centers.

3. Rising Demand for Fertility Preservation: As more women delay childbirth and seek fertility preservation options like egg freezing, the demand for AMH testing is increasing. AMH tests are essential in assessing ovarian reserve, making them a critical tool in fertility preservation decisions.

4. Government Support for Fertility Services: Governments in many regions are providing support for fertility treatments through subsidies and insurance coverage. This has led to an increase in the availability of AMH testing as part of assisted reproductive technologies like IVF, fostering market growth.

5. Integration with Assisted Reproductive Technologies (ART): The growing use of ART procedures such as IVF and IUI has driven demand for AMH testing. By assessing ovarian reserve, AMH tests help tailor ART treatments for better success rates, further integrating them into fertility care protocols.

Challenges in the AMH FIA test market are:

1. High Cost of Testing: The cost of AMH testing can be a significant barrier, especially in developing regions where healthcare spending is limited. The high cost of tests may restrict access to a larger demographic, limiting market expansion.

2. Limited Access in Rural Areas: Despite the increasing availability of AMH testing in urban areas, access to these tests remains limited in rural and remote regions, especially in emerging markets. This disparity hinders broader market adoption and access to fertility care.

3. Regulatory Hurdles: The regulatory landscape surrounding AMH testing is complex, with varying standards across different regions. Stringent regulations and approvals can delay the market entry of new testing technologies and hinder growth in certain regions.

The drivers and challenges impacting the AMH FIA test market reflect a dynamic landscape of opportunities and obstacles. Rising fertility awareness, technological advancements, and government support are driving growth, while cost, access issues, and regulatory hurdles present challenges. These factors will continue to shape the market's evolution.

List of AMH FIA Test Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies AMH FIA test companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the AMH FIA test companies profiled in this report include-

• CTK Biotech
• Medline
• Guangzhou Wanfu Biology Technology
• Biotime
• Wondfo
• Biolab Diagnostics
• Boditech Med

AMH FIA Test Market by Segment

The study includes a forecast for the global AMH FIA test market by type, application, and region.

AMH FIA Test Market by Type [Value from 2019 to 2031]:

• Cryogenic Storage
• Room Temperature Storage

AMH FIA Test Market by Application [Value from 2019 to 2031]:

• Medical
• Scientific Research
• Others

AMH FIA Test Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the AMH FIA Test Market

The AMH FIA (Anti-Mullerian Hormone Fluorescent Immunoassay) test market has seen notable advancements globally, with significant changes in the U.S., China, Germany, India, and Japan. These developments reflect shifts in healthcare trends, increasing awareness of fertility issues, and advancements in diagnostic technology. The AMH test, used to assess ovarian reserve, is gaining popularity in fertility clinics and healthcare settings as an essential tool for assessing fertility potential. These regions are adopting the test at varying rates, influenced by regional healthcare infrastructure, demand for reproductive health solutions, and the availability of advanced technologies.

• United States: In the U.S., the AMH FIA test market has experienced significant growth, driven by rising fertility concerns, an increasing number of fertility clinics, and the adoption of fertility preservation technologies. There is a growing demand for AMH testing in reproductive health services, where the test helps women understand their ovarian reserve. The market benefits from technological advancements, with several clinics offering more precise and faster testing solutions. Additionally, the rise of egg freezing and fertility treatments such as IVF is contributing to higher demand for AMH testing, making it a core service in fertility care.
• China: In China, the AMH FIA test market has seen steady growth, driven by a rapidly aging population and the increasing focus on women's health. With fertility challenges becoming more common due to delayed childbirth, AMH testing has gained popularity as a tool for assessing ovarian reserve. In addition to fertility clinics, AMH testing is increasingly offered by hospitals and healthcare centers, contributing to broader access. The Chinese government's support of fertility treatments and technologies has further driven the market. However, there are regional disparities in access to such testing services, limiting widespread adoption in rural areas.
• Germany: Germany has established itself as a leader in the AMH FIA test market in Europe. The country's advanced healthcare system and high demand for fertility services contribute to the widespread availability of AMH testing in clinics and hospitals. With a focus on reproductive health and the increasing popularity of IVF and fertility preservation, Germany has integrated AMH tests into its fertility diagnostic protocols. Furthermore, research and development in the country are advancing, with innovations improving the accuracy and cost-effectiveness of AMH testing. This has positioned Germany as a key player in the European market for AMH FIA tests.
• India: In India, the AMH FIA test market is expanding due to rising fertility awareness, especially among urban populations. Fertility clinics are increasingly adopting AMH tests to assess ovarian reserve, with a growing number of women seeking fertility preservation services. The country's large population and the rising incidence of infertility have driven demand for reproductive health solutions. However, challenges such as limited access to high-end medical facilities in rural areas and financial constraints on fertility treatments have somewhat slowed market penetration. Nevertheless, the demand for affordable fertility care is pushing the adoption of AMH tests in both private and public healthcare sectors.
• Japan: In Japan, the AMH FIA test market is advancing, with an increasing focus on fertility preservation and reproductive health due to the aging population and delayed childbirth trends. AMH testing is widely used in fertility clinics, hospitals, and research institutions. Japan's advanced healthcare infrastructure and rising infertility rates contribute to the growing demand for AMH tests. The market is also influenced by the government's initiatives to support fertility treatments, which include AMH testing as part of diagnostic protocols. However, cultural factors and healthcare regulations surrounding fertility services remain challenges in further market expansion.

Features of the Global AMH FIA Test Market

• Market Size Estimates: AMH FIA test market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: AMH FIA test market size by type, application, and region in terms of value ($B).
• Regional Analysis: AMH FIA test market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the AMH FIA test market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the AMH FIA test market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the AMH FIA test market by type (cryogenic storage and room temperature storage), application (medical, scientific research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global AMH FIA Test Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Cryogenic Storage: Trends and Forecast (2019-2031)
• 4.4 Room Temperature Storage: Trends and Forecast (2019-2031)

5. Global AMH FIA Test Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Medical: Trends and Forecast (2019-2031)
• 5.4 Scientific Research: Trends and Forecast (2019-2031)
• 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global AMH FIA Test Market by Region

7. North American AMH FIA Test Market

• 7.1 Overview
• 7.4 United States AMH FIA Test Market
• 7.5 Mexican AMH FIA Test Market
• 7.6 Canadian AMH FIA Test Market

8. European AMH FIA Test Market

• 8.1 Overview
• 8.4 German AMH FIA Test Market
• 8.5 French AMH FIA Test Market
• 8.6 Spanish AMH FIA Test Market
• 8.7 Italian AMH FIA Test Market
• 8.8 United Kingdom AMH FIA Test Market

9. APAC AMH FIA Test Market

• 9.1 Overview
• 9.4 Japanese AMH FIA Test Market
• 9.5 Indian AMH FIA Test Market
• 9.6 Chinese AMH FIA Test Market
• 9.7 South Korean AMH FIA Test Market
• 9.8 Indonesian AMH FIA Test Market

10. ROW AMH FIA Test Market

• 10.1 Overview
• 10.4 Middle Eastern AMH FIA Test Market
• 10.5 South American AMH FIA Test Market
• 10.6 African AMH FIA Test Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global AMH FIA Test Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 CTK Biotech
  • Company Overview
  • AMH FIA Test Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Medline
  • Company Overview
  • AMH FIA Test Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Guangzhou Wanfu Biology Technology
  • Company Overview
  • AMH FIA Test Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Biotime
  • Company Overview
  • AMH FIA Test Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Wondfo
  • Company Overview
  • AMH FIA Test Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Biolab Diagnostics
  • Company Overview
  • AMH FIA Test Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Boditech Med
  • Company Overview
  • AMH FIA Test Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us